$HBAN

HBAN falls after Huntington trims guidance at Barclays conference

Huntington Bancshares (HBAN) shares fell 5.3% after lowering 2026 net interest income growth guidance to 35% from 39-43% and adopting a more conservative 2027 EPS target range of $1.75-$1.83, citing weaker loan volume and pressure on net interest margin.

Original reporting
Published Sep 16, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 12:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HBAN falls after Huntington trims guidance at Barclays conference — source image
Decision brief

The 30-second read

$HBANBearishHigh
01

Why it matters

The guidance downgrade signals tighter margins and slower loan growth, likely prompting short‑term selling.

02

Market read

Guidance reset is a material corporate event for HBAN, affecting earnings expectations and stock price.

03

What to watch

The guidance cut may be offset by a stronger balance sheet and low credit losses.

Relevance 7/10Novelty 8/10Timing: today

Background

HBAN presented its September 16 investor presentation at a Barclays conference, filing the details on Form 8‑K.

Company-level read

Ticker impact

$HBANBearishHigh confidence
Context

HBAN disclosed a trimmed 2026 NII growth guidance to ~35% and a lower 2027 EPS range of $1.75‑$1.83 in a Form 8‑K filing, prompting a 5.3% price drop.

Expected impact

downward pressure on HBAN stock in the near term

Evidence & confidence

The guidance reset is a primary disclosure with concrete numbers that directly affect earnings expectations, likely driving further sell‑offs.

Market effects

May weigh on regional banks and lenders with similar exposure to CRE and deposit cost pressures.

Potentially drags Mid‑Atlantic banking stocks in the same trading session.

Limited; primarily a US regional banking story.

Counterpoint

If the market overreacts, the stock could rebound on the announced share repurchase program.

Key entities

  • Huntington Bancshares Inc.

    Issuer of the guidance update.

Related articles

$HBANMed

Stocks fall after Federal Reserve raises interest rates

U.S. stocks fell Wednesday after the Federal Reserve raised interest rates, with the S&P 500 down 0.4% and the Dow Jones dropping 1.2%. Fed Chairman Kevin Warsh indicated more hikes may come as inflation remains high. Traders expect rates to reach 4.25%-4.50% by year-end. Bank stocks declined, while AI-related stocks like Nvidia and AMD rose.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$HBANHigh

Why is Huntington Bancshares stock sliding today?

Huntington Bancshares (HBAN) stock fell 2.0% to $16.41 in pre-market trading after lowering its fiscal 2027 EPS guidance to $1.75-$1.83, down from $1.90-$1.93, and revising 2026 net interest income growth forecast lower. The bank cited high short-term rates and deposit pricing competition. The stock's ex-dividend date is September 17.

$HBANMed

HBAN Looks 0.2% Undervalued on GF Value™ as Dividend Sustainabil

Huntington Bancshares (HBAN) promoted Brant Standridge to president, potentially positioning him as a future CEO. The company offers a 3.73% dividend yield with a 42% payout ratio, and its stock is fairly valued at $16.62 vs. GF Value™ of $16.66. HBAN has a GF Score™ of 79, with strengths in growth and valuation but weaker financial strength. Insiders have sold more shares than purchased, and institutional investors show mixed sentiment.

$HBANMed

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.